RU2333202C2 - 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции - Google Patents

2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции Download PDF

Info

Publication number
RU2333202C2
RU2333202C2 RU2005132163/04A RU2005132163A RU2333202C2 RU 2333202 C2 RU2333202 C2 RU 2333202C2 RU 2005132163/04 A RU2005132163/04 A RU 2005132163/04A RU 2005132163 A RU2005132163 A RU 2005132163A RU 2333202 C2 RU2333202 C2 RU 2333202C2
Authority
RU
Russia
Prior art keywords
butyl
sulfonylamino
methoxypyridin
propyl
benzamide
Prior art date
Application number
RU2005132163/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2005132163A (ru
Inventor
Йоахим Брендель
Хайнц Гегеляйн
Клаус ВИРТ
Герт Ульрих КЮРЦЕЛЬ
Original Assignee
Санофи-Авентис Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис Дойчланд Гмбх filed Critical Санофи-Авентис Дойчланд Гмбх
Publication of RU2005132163A publication Critical patent/RU2005132163A/ru
Application granted granted Critical
Publication of RU2333202C2 publication Critical patent/RU2333202C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
RU2005132163/04A 2003-03-18 2004-03-05 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции RU2333202C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10312073.4 2003-03-18
DE10312073A DE10312073A1 (de) 2003-03-18 2003-03-18 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen

Publications (2)

Publication Number Publication Date
RU2005132163A RU2005132163A (ru) 2006-04-10
RU2333202C2 true RU2333202C2 (ru) 2008-09-10

Family

ID=32920928

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005132163/04A RU2333202C2 (ru) 2003-03-18 2004-03-05 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции

Country Status (22)

Country Link
EP (1) EP1606237A1 (sr)
JP (1) JP2006520343A (sr)
KR (1) KR20050110681A (sr)
CN (1) CN100361943C (sr)
AR (1) AR043622A1 (sr)
AU (1) AU2004222137A1 (sr)
BR (1) BRPI0408441A (sr)
CA (1) CA2519022A1 (sr)
DE (1) DE10312073A1 (sr)
HK (1) HK1086819A1 (sr)
HR (1) HRP20050815A2 (sr)
MA (1) MA27749A1 (sr)
MX (1) MXPA05009763A (sr)
MY (1) MY176510A (sr)
NO (1) NO20054472L (sr)
NZ (1) NZ542476A (sr)
PE (1) PE20050307A1 (sr)
RS (1) RS20050690A (sr)
RU (1) RU2333202C2 (sr)
TW (1) TW200500342A (sr)
WO (1) WO2004083157A1 (sr)
ZA (1) ZA200506328B (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009931A1 (de) * 2004-02-26 2005-09-15 Aventis Pharma Deutschland Gmbh Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
DE102005028845A1 (de) * 2005-06-22 2006-12-28 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
WO2007015775A2 (en) * 2005-07-22 2007-02-08 Merck & Co., Inc. Potassium channel inhibitors
JP5685203B2 (ja) 2009-05-29 2015-03-18 ラクオリア創薬株式会社 カルシウムチャネル遮断薬またはナトリウムチャネル遮断薬としてのアリール置換カルボキサミド誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
HK1086819A1 (en) 2006-09-29
NO20054472L (no) 2005-09-27
MY176510A (en) 2020-08-12
RU2005132163A (ru) 2006-04-10
DE10312073A1 (de) 2004-09-30
PE20050307A1 (es) 2005-06-08
CN1756728A (zh) 2006-04-05
CN100361943C (zh) 2008-01-16
NZ542476A (en) 2008-05-30
KR20050110681A (ko) 2005-11-23
TW200500342A (en) 2005-01-01
ZA200506328B (en) 2006-04-26
CA2519022A1 (en) 2004-09-30
HRP20050815A2 (en) 2006-09-30
EP1606237A1 (de) 2005-12-21
AR043622A1 (es) 2005-08-03
MXPA05009763A (es) 2006-01-27
AU2004222137A1 (en) 2004-09-30
BRPI0408441A (pt) 2006-04-04
RS20050690A (sr) 2008-04-04
JP2006520343A (ja) 2006-09-07
WO2004083157A1 (de) 2004-09-30
MA27749A1 (fr) 2006-02-01

Similar Documents

Publication Publication Date Title
CN100548300C (zh) 雷诺嗪在用于制备治疗心律失常药剂中的应用
EP1385820B1 (de) Anthranilsäureamide, verfahren zu ihrer herstellung, ihre verwendung als antiarrhythmika sowie pharmazeutische zubereitungen davon
RU2275366C2 (ru) Арилированные амиды фуран- и тиофенкарбоновых кислот с блокирующим калиевый канал действием
EP1399423B1 (de) Anthranilsäureamide mit heteroarylsulfonyl-seitenkette und ihre verwendung als antiarrhythmische wirkstoffe
DE60133323T2 (de) Cardioprotektive Phosphonate
WO2002087568A1 (de) Verwendung von anthranilsäureamiden als medikament zur behandlung von arrhythmien sowie sie enthaltende pharmazeutische zubereitungen
DE69917074T2 (de) Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten
RU2333202C2 (ru) 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции
WO2002045750A1 (fr) Medicaments combines
WO2015192672A1 (zh) 苯并呋喃类衍生物、其制备方法和应用
CN102001971B (zh) N-(4-胍基丁基)丁香酰胺衍生物及其医药用途
EP1720549A1 (de) Kv1.5-blocker zur selektiven steigerung der vorhofkontraktilität und behandlung der herzinsuffizienz
JP7032323B2 (ja) Ｎ－ホルミルペプチド受容体モジュレーターとしてのフェニル尿素誘導体
US20080081926A1 (en) Sulfonylaminobenzoic acid and salt
CN105792821A (zh) 包含1-茚满硫酰胺衍生物的疼痛治疗剂和/或预防剂
CN102796092B (zh) 噁唑烷酮衍生物及其制备方法和应用
JP2003026677A (ja) ３−フェニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、これを含有する医薬品、その使用及びその製法
WO2005025674A1 (de) Kombination von phenylcarbonsäureamiden mit beta-adrenozeptoren-blockern und deren verwendung zur behandlung von vorhofarrhythmien
JPH09118635A (ja) クラスｉｉｉおよびクラスｉｖ抗不整脈活性を有するジアミン化合物
CN101198605A (zh) N-(吡啶-2-基)-磺酰胺衍生物
JPH0662609B2 (ja) 新規（‐）２‐ピラゾリン化合物及びそれを有効成分とする脳血管障害治療剤

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20110306